Area of expertise: Drug discovery of antibacterials
Laura Cleghorn
Tuberculosis Portfolio Leader and Reader
Drug Discovery Unit (DDU), University of Dundee
more
Anthony Coates
Professor of Medical Microbiology and Founder/CSO
St. George’s University, Helperby Therapeutics
more
James Collins
Professor of Medical Engineering & Science and Biological Engineering
Massachusetts Institute of Technology (MIT)
more
Matthew Cooper
Chief Executive Officer
Inflazome
more
Lloyd Czaplewski
Chief Scientific Officer
Persica Pharmaceuticals
more
Mike Dawson
Director
Mike Dawson Antimicrobial Research Consultancy
more
Rosemary Dorrington
DST/NRF SARChI Professor: Marine Natural Products Research
Rhodes University
more
Christopher Dowson
Professor of Microbiology
Warwick University
more
James Duffy
Senior Director, Drug Discovery
Medicines for Malaria Venture (MMV), Switzerland
more
Miquel Duran-Frigola
Co-Founder and Science and Technology Director
Ersilia Open Source Initiative
more